Hello It's a shame I used it in an old project and its integration with
annotators implemented in C++ and Python was fantastic. Unfortunately I
don't have much free time to help, because I currently work for Openbravo
and time is short, and I have to live on something.
My symbolic vote: -1.

Best Regards

El mié, 7 dic 2022 a las 3:19, Peter Klügl
(<peter.klu...@averbis.com.invalid>) escribió:

> [x] +1 - go on and retire
>
> Peter
>
> Am 07.12.2022 um 08:46 schrieb Richard Eckart de Castilho:
> > Hi all,
> >
> > I propose to retire the UIMA C++ SDK on Dec 21 2022.
> >
> > The original creators and maintainers of UIMA C++ SDK are no longer
> working on it
> > leaving the codebase unmaintained.
> >
> > We currently have no CI build set up for UIMA C++ SDK. We do not know if
> it remains
> > compatible with the latest developments in the UIMA Java SDK and nobody
> has the
> > resources to be testing it even manually.
> >
> > As part of retiring this sub-project, I suggest we should:
> >
> > * remove it from the UIMA website's download section
> > * remove references to it in general from the UIMA website except maybe
> >   keeping a reference to the archived downloads
> > * put up a note in the git repo stating that the project is retired,
> >   does no longer get updates and may contain bugs or security problems.
> > * ask INFRA to mark the github mirror as archived - or -
> >   if they prefer remove the github mirror completely only keeping an
> >   archived mirror at the ASF.
> >
> > [ ] +1 - go on and retire
> > [ ] 0  - I don't care
> > [ ] -1 - do not retire
> >
> > Note that anybody voting -1 should step up as a new maintainer at the
> same time.
> >
> > Best,
> >
> > -- Richard
> >
> --
> Dr. Peter Klügl
> Head of Text Mining/Machine Learning
>
> Averbis GmbH
> Salzstr. 15
> 79098 Freiburg
> Germany
>
> Fon: +49 761 708 394 0
> Fax: +49 761 708 394 10
> Email: peter.klu...@averbis.com
> Web: https://averbis.com
>
> Headquarters: Freiburg im Breisgau
> Register Court: Amtsgericht Freiburg im Breisgau, HRB 701080
> Managing Directors: Dr. med. Philipp Daumke, Dr. Kornél Markó
>
>

Reply via email to